alginate oligosaccharide

DRUG2 trials

Sponsors

AlgiPharma AS

Conditions

Burkholderia InfectionCystic Fibrosis

Phase 2

A Phase IIb Study of OligoG in Subjects With Cystic Fibrosis

CompletedNCT02157922

AlgiPharma ASCystic Fibrosis

Start: 2014-10-31End: 2017-09-30Updated: 2018-04-19

A Study of OligoG in Cystic Fibrosis Subjects With Burkholderia Spp. Infection

CompletedNCT02453789

AlgiPharma ASBurkholderia Infection, Cystic Fibrosis

Start: 2015-02-28End: 2017-12-31Updated: 2018-04-19

Related Papers

Implementation of microbiota analysis in clinical trials for cystic fibrosis lung infection: Experience from the OligoG phase 2b clinical trials.

2021-01-076 citations